The World Health Organization's vaccine advisory panel has tentatively scheduled a review of the Astrazeneca COVID-19 vaccine for February 8, an expert said on Tuesday.
"Reviewing the data from AstraZeneca, and we have tentatively - I have to underline tentatively - scheduled a meeting of SAGE to discuss policy recommendation on February 8th," Joachim Hombach, executive secretary of WHO's Strategic Advisory Group of Experts on Immunisation (SAGE), told a news briefing held as it issued recommendations on the use of the Moderna vaccine.